Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("PELKONEN RO")

Results 1 to 13 of 13

  • Page / 1

Export

Selection :

  • and

MEASUREMENT OF HEPATIC DRUG-METABOLIZING ENZYME ACTIVITY IN MAN. COMPARISON OF THREE DIFFERENT ASSAYSSOTANIEMI EA; PELKONEN RO; PUUKKA M et al.1980; EUROP. J. CLIN. PHARMACOL.; DEU; DA. 1980; VOL. 17; NO 4; PP. 267-274; BIBL. 40 REF.Article

HEPATIC BLOOD FLOW AND DRUG METABOLISM IN PATIENTS ON ENZYME-INDUCING ANTICONVULSANTSPIRTTIAHO HI; SOTANIEMI EA; PELKONEN RO et al.1982; EUR. J. CLIN. PHARMACOL.; ISSN 0031-6970; DEU; DA. 1982; VOL. 22; NO 5; PP. 441-445; BIBL. 24 REF.Article

DRUG METABOLISM IN EPILEPTICS: IN VIVO AND IN VITRO CORRELATIONS.SOTANIEMI EA; PELKONEN RO; AHOKAS J et al.1978; BRIT. J. CLIN. PHARMACOL.; G.B.; DA. 1978; VOL. 5; NO 1; PP. 71-76; BIBL. 23 REF.Article

RELATIONSHIP BETWEEN IN VIVO AND IN VIVO DRUG METABOLISM IN MAN.SOTANIEMI EA; PELKONEN RO; AHOKAS JT et al.1978; EUROP. J. DRUG. METABOL. PHARMACOKINET.; FR.; DA. 1978; VOL. 3; NO 1; PP. 39-45; BIBL. 1 P. 1/2Article

PLASMA CLEARANCE OF PROPRANOLOL AND SOTALOL AND HEPATIC DRUG-METABOLIZING ENZYME ACTIVITYSOTANIEMI EA; ANTTILA M; PELKONEN RO et al.1979; CLIN. PHARMACOL. THERAPEUT.; USA; DA. 1979; VOL. 26; NO 2; PP. 153-161; BIBL. 39 REF.Article

LIVER SIZE AND INDICES OF DRUG METABOLISM IN ALCOHOLICS.PIRTTIAHO HI; SOTANIEMI EA; AHLQVIST J et al.1978; EUROP. J. CLIN. PHARMACOL.; GERM.; DA. 1978; VOL. 13; NO 1; PP. 61-67; BIBL. 1 P.Article

HISTOLOGICAL CHANGES IN THE LIVER AND INDICES OF DRUG METABOLISM IN ALCOHOLICS.SOTANIEMI EA; AHLQVIST J; PELKONEN RO et al.1977; EUROP. J. CLIN. PHARMACOL.; GERM.; DA. 1977; VOL. 11; NO 4; PP. 295-303; BIBL. 41 REF.Article

BLOOD LACTATE, HEPATIC HISTOLOGY AND MICROSOMAL ENZYME ACTIVITY IN NON-INSULIN-DEPENDENT DIABETICSSALMELA PI; SOTANIEMI EA; PELKONEN RO et al.1983; DIABETE ET METABOLISME; ISSN 0338-1684; FRA; DA. 1983; VOL. 9; NO 2; PP. 100-105; ABS. FRE; BIBL. 41 REF.Article

HEPATIC INJURY AND DRUG METABOLISM IN PATIENTS WITH ALPHA-METHYLDOPA-INDUCED LIVER DAMAGE.SOTANIEMI EA; HOKKANEN OT; AHOKAS JT et al.1977; EUROP. J. CLIN. PHARMACOL.; GERM.; DA. 1977; VOL. 12; NO 6; PP. 429-435; BIBL. 32 REF.Article

IMPAIRMENT OF DRUG METABOLISM IN PATIENTS WITH LIVER CANCER.SOTANIEMI EA; PELKONEN RO; MOKKA RE et al.1977; EUROP. J. CLIN. INVEST.; GERM.; DA. 1977; VOL. 7; NO 4; PP. 269-274; BIBL. 28 REF.Article

PLASMA HIGH-DENSITY LIPOPROTEIN CHOLESTEROL AND HEPATIC CYTOCHROME P-450 CONCENTRATIONS IN EPILEPTICS UNDERGOING ANTICONVULSANT TREATMENTLUOMA PV; SOTANIEMI EA; PELKONEN RO et al.1980; SCAND. J. CLIN. LAB. INVEST.; NOR; DA. 1980; VOL. 40; NO 2; PP. 163-167; BIBL. 21 REF.Article

PLASMA HIGH-DENSITY LIPOPROTEINS AND HEPATIC MICROSOMAL ENZYME INDUCTION. RELATION TO HISTOLOGICAL CHANGES IN THE LIVERLUOMA PV; SOTANIEMI EA; PELKONEN RO et al.1982; EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY; ISSN 0031-6970; DEU; DA. 1982; VOL. 23; NO 3; PP. 275-282; BIBL. 55 REF.Article

ROLES OF HEPATIC BLOOD FLOW AND ENZYME ACTIVITY IN THE KINETICS OF PROPRANOLOL AND SOTALOLPIRTTIAHO HI; SOTANIEMI EA; PELKONEN RO et al.1980; BRIT. J. CLIN. PHARMACOL.; GBR; DA. 1980; VOL. 9; NO 4; PP. 399-405; BIBL. 34 REF.Article

  • Page / 1